JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today U.S. Food and Drug Administration (FDA) approval and commercial launch of Anastrozole Tablets 1 mg, the Company’s generic version of AstraZeneca’s ARIMIDEX®. The product is indicated for treatment of certain forms of breast cancer in postmenopausal women.
